Erkan Baloglu
Karyopharm Therapeutics (United States)(US)
Publications by Year
Research Areas
Nuclear Structure and Function, Cancer-related Molecular Pathways, RNA Research and Splicing, Myeloproliferative Neoplasms: Diagnosis and Treatment, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group(2013)370 cited
- → The Taxane Diterpenoids(1999)307 cited
- → Nucleo-cytoplasmic transport as a therapeutic target of cancer(2014)279 cited
- → Small-Molecule RORγt Antagonists Inhibit T Helper 17 Cell Transcriptional Network by Divergent Mechanisms(2014)276 cited
- → Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma(2016)234 cited
- → XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer(2016)208 cited
- → Novel phenanthridinone inhibitors of poly(adenosine 5′-diphosphate-ribose) synthetase: Potent cytoprotective and antishock agents*(2002)185 cited
- → PAK4 inhibition improves PD-1 blockade immunotherapy(2019)156 cited
- → A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action(2017)143 cited
- → Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases Kidney Cancer Growth(2016)141 cited